Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects
Nanoscale · 2025
DOI: 10.1039/d5nr03373j ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2025. Verfasst von Nadine Wafik Nabih und 4 weiteren Autor:innen. Beteiligte Einrichtung: Organic and Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Sadat City, Menoufia, 32897, Egypt. Hauptthemen laut MEDLINE: Parkinson Disease, Drug Carriers, Lipids, Nanoparticles. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Alexander von Humboldt-Stiftung, Philipps-Universität Marburg.
Abstract (Originalsprache)
Parkinson's disease (PD) remains one of the most formidable challenges in central nervous system (CNS) drug delivery due to the restrictive blood–brain barrier (BBB) and limited efficacy of current dopaminergic therapies. Created in BioRender. Fahmy, S. (2025) https://BioRender.com/vsusgrv.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Organic and Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Sadat City, Menoufia, 32897, Egypt.
- Department of Chemistry, College of Sciences, University of Sharjah, Sharjah P.O. 27272, United Arab Emirates (UAE). mohamed.elsayed@sharjah.ac.ae.
- Chemistry Department, Faculty of Science, Suez Canal University, P.O. 41522, Ismailia, Egypt. mohamed_nafie@science.suez.edu.eg.
- Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.
- Department of Chemical Pathology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan.
Förderung
- Alexander von Humboldt-Stiftung
- Philipps-Universität Marburg
Zitieren
APA
Wafik Nabih, N., Nafie, M. S., Babker, A., Alameen, A. A. M., & Fahmy, S. A. (2025). Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects. Nanoscale. https://doi.org/10.1039/d5nr03373j
Vancouver
Wafik Nabih N, Nafie MS, Babker A, Alameen AAM, Fahmy SA. Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects. Nanoscale. 2025. doi:10.1039/d5nr03373j
BibTeX
@article{WafikNabih2025,
author = {Wafik Nabih, Nadine and Nafie, Mohamed S and Babker, Asaad and Alameen, Ayman Ali Mohammed and Fahmy, Sherif Ashraf},
title = {Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects},
journal = {Nanoscale},
year = {2025},
doi = {10.1039/d5nr03373j}
}
EUVIMED